trimetazidine has been researched along with carnitine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ribeiro, C | 1 |
| Chierchia, SL; Fragasso, G | 1 |
| Iliceto, S; Marangelli, V; Rizzon, P | 1 |
| Andreadou, I; Cicchitelli, G; Ferrari, R; Guardigli, G; Merli, E | 1 |
| Hill, JA; Schofield, RS | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Arora, R; Parang, P; Singh, B | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Lango, R | 1 |
| Guo, T; Wang, J | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
| Liu, C; Wang, Y; Xing, Y; Zhang, W; Zhang, X | 1 |
10 review(s) available for trimetazidine and carnitine
| Article | Year |
|---|---|
Metabolic management of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Energy Metabolism; Humans; Myocardium; Nitroglycerin; Piperazines; Ranolazine; Trimetazidine | 1993 |
Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Topics: Acetanilides; Carnitine; Clinical Trials as Topic; Coenzymes; Coronary Disease; Enzyme Inhibitors; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Superoxide Dismutase; Trimetazidine; Ubiquinone; Vasodilator Agents | 1995 |
Metabolic modulation and optimization of energy consumption in heart failure.
Topics: Acetanilides; Cardiac Pacing, Artificial; Cardiotonic Agents; Carnitine; Energy Metabolism; Heart Failure; Humans; Piperazines; Ranolazine; Trimetazidine | 2003 |
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
Metabolic modulators for chronic cardiac ischemia.
Topics: Acetanilides; Animals; Carnitine; Chronic Disease; Drug Evaluation, Preclinical; Enzyme Inhibitors; Heart; Humans; Lipid Metabolism; Myocardial Ischemia; Myocardium; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2005 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
[Regulation of myocardial metabolism: possibilities and application in cardiac surgery].
Topics: Acetanilides; Animals; Cardiac Surgical Procedures; Cardiotonic Agents; Carnitine; Drug Therapy, Combination; Glucose; Glutamine; Humans; Insulin; Intraoperative Care; Myocardial Stunning; Myocardium; Myocytes, Cardiac; Piperazines; Potassium; Ranolazine; Trimetazidine; Vasodilator Agents | 2003 |
Metabolic remodeling in chronic heart failure.
Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Carnitine; Energy Metabolism; Fatty Acids; Fetal Heart; Glucose; Heart Failure; Humans; Neurotransmitter Agents; Thiamine; Trimetazidine; Ventricular Remodeling | 2013 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
4 other study(ies) available for trimetazidine and carnitine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 1994 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |
Trimetazidine and l‑carnitine prevent heart aging and cardiac metabolic impairment in rats via regulating cardiac metabolic substrates.
Topics: Aging; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Echocardiography; Glucose Transporter Type 4; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Trimetazidine; Ventricular Function, Left | 2019 |